Invex Other Operating Expenses vs Total Revenue Analysis

IXC Stock   0.07  0  4.17%   
Invex Therapeutics financial indicator trend analysis is infinitely more than just investigating Invex Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Invex Therapeutics is a good investment. Please check the relationship between Invex Therapeutics Other Operating Expenses and its Total Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Operating Expenses vs Total Revenue

Other Operating Expenses vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Invex Therapeutics Other Operating Expenses account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Invex Therapeutics' Other Operating Expenses and Total Revenue is 0.56. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Invex Therapeutics, assuming nothing else is changed. The correlation between historical values of Invex Therapeutics' Other Operating Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Invex Therapeutics are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Other Operating Expenses i.e., Invex Therapeutics' Other Operating Expenses and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.56
Relationship DirectionPositive 
Relationship StrengthWeak

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Invex Therapeutics. It is also known as Invex Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Revenue

Total revenue comprises all receipts Invex Therapeutics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.
Most indicators from Invex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.1 M in 2024.
 2022 2023 2024 (projected)
Gross Profit459.1K1.2M1.3M
Total Revenue459.1K1.2M1.3M

Invex Therapeutics fundamental ratios Correlations

0.51.00.48-1.0-0.04-0.331.0-0.460.461.00.150.49-0.210.15-0.530.51.00.66-0.280.460.410.640.850.64
0.50.46-0.03-0.490.190.180.49-0.540.530.490.44-0.02-0.510.440.261.00.50.130.260.530.140.410.280.41
1.00.460.5-1.0-0.05-0.351.0-0.440.441.00.130.5-0.190.13-0.550.461.00.67-0.30.440.420.630.860.63
0.48-0.030.5-0.5-0.85-0.790.490.52-0.430.490.350.99-0.310.35-0.89-0.030.490.92-0.92-0.43-0.04-0.340.44-0.34
-1.0-0.49-1.0-0.50.050.35-1.00.45-0.44-1.0-0.15-0.50.2-0.150.54-0.49-1.0-0.670.29-0.44-0.41-0.63-0.85-0.63
-0.040.19-0.05-0.850.050.55-0.04-0.720.7-0.04-0.59-0.870.51-0.590.740.19-0.04-0.750.920.70.210.7-0.190.7
-0.330.18-0.35-0.790.350.55-0.34-0.550.55-0.340.16-0.76-0.230.160.650.18-0.33-0.670.580.55-0.090.34-0.080.34
1.00.491.00.49-1.0-0.04-0.34-0.450.451.00.140.49-0.20.14-0.530.491.00.66-0.290.450.410.630.850.63
-0.46-0.54-0.440.520.45-0.72-0.55-0.45-0.8-0.450.030.490.050.03-0.35-0.54-0.450.21-0.58-0.8-0.36-0.9-0.45-0.9
0.460.530.44-0.43-0.440.70.550.45-0.80.45-0.11-0.45-0.04-0.110.350.530.45-0.310.521.00.350.890.360.89
1.00.491.00.49-1.0-0.04-0.341.0-0.450.450.140.49-0.20.14-0.530.491.00.66-0.290.450.410.630.850.63
0.150.440.130.35-0.15-0.590.160.140.03-0.110.140.44-0.981.0-0.280.440.150.49-0.46-0.11-0.06-0.240.4-0.24
0.49-0.020.50.99-0.5-0.87-0.760.490.49-0.450.490.44-0.390.44-0.91-0.020.490.95-0.93-0.450.01-0.340.49-0.34
-0.21-0.51-0.19-0.310.20.51-0.23-0.20.05-0.04-0.2-0.98-0.39-0.980.24-0.51-0.21-0.440.41-0.040.020.13-0.440.13
0.150.440.130.35-0.15-0.590.160.140.03-0.110.141.00.44-0.98-0.280.440.150.49-0.46-0.11-0.06-0.240.4-0.24
-0.530.26-0.55-0.890.540.740.65-0.53-0.350.35-0.53-0.28-0.910.24-0.280.26-0.53-0.90.930.35-0.130.15-0.650.15
0.51.00.46-0.03-0.490.190.180.49-0.540.530.490.44-0.02-0.510.440.260.50.130.260.530.140.410.280.41
1.00.51.00.49-1.0-0.04-0.331.0-0.450.451.00.150.49-0.210.15-0.530.50.67-0.290.450.410.630.850.63
0.660.130.670.92-0.67-0.75-0.670.660.21-0.310.660.490.95-0.440.49-0.90.130.67-0.85-0.310.11-0.120.69-0.12
-0.280.26-0.3-0.920.290.920.58-0.29-0.580.52-0.29-0.46-0.930.41-0.460.930.26-0.29-0.850.520.120.44-0.450.44
0.460.530.44-0.43-0.440.70.550.45-0.81.00.45-0.11-0.45-0.04-0.110.350.530.45-0.310.520.350.890.360.89
0.410.140.42-0.04-0.410.21-0.090.41-0.360.350.41-0.060.010.02-0.06-0.130.140.410.110.120.350.460.380.46
0.640.410.63-0.34-0.630.70.340.63-0.90.890.63-0.24-0.340.13-0.240.150.410.63-0.120.440.890.460.551.0
0.850.280.860.44-0.85-0.19-0.080.85-0.450.360.850.40.49-0.440.4-0.650.280.850.69-0.450.360.380.550.55
0.640.410.63-0.34-0.630.70.340.63-0.90.890.63-0.24-0.340.13-0.240.150.410.63-0.120.440.890.461.00.55
Click cells to compare fundamentals

Invex Therapeutics Account Relationship Matchups

Invex Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets26.4M32.7M29.5M22.8M6.1M5.8M
Total Current Liabilities2.0M658.6K1.0M1.6M431.6K410.0K
Total Stockholder Equity24.4M32.1M28.5M21.2M5.7M5.4M
Net Debt(26.3M)(32.7M)(29.3M)(22.5M)(6.0M)(6.3M)
Retained Earnings(3.6M)(5.9M)(9.8M)(17.6M)(19.2M)(18.3M)
Accounts Payable30.4K11.3K138.8K1.1M5.6K5.3K
Cash26.3M32.7M29.3M22.5M6.0M5.7M
Cash And Short Term Investments26.3M32.7M29.3M22.5M6.0M5.7M
Net Receivables116.9K21.2K145.7K333.6K95.0K146.3K
Liabilities And Stockholders Equity26.4M32.7M29.5M22.8M6.1M5.8M
Inventory(116.9K)(21.2K)(145.7K)(333.6K)(95.0K)(99.7K)
Other Current Assets116.9K21.2K145.7K333.6K95.0K146.3K
Other Stockholder Equity977.2K(30.5M)(26.6M)(18.8M)(17.0M)(17.8M)
Total Liab2.0M658.6K1.0M1.6M431.6K410.0K
Total Current Assets26.4M32.7M29.5M22.8M6.1M5.8M
Accumulated Other Comprehensive Income977.2K1.5M1.9M2.4M2.5M1.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Invex Stock Analysis

When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.